ConnectiCare has contracted with Magellan Rx Management (Magellan Rx) to manage the review of preauthorization requests for the following specialty drugs for both our commercial and Medicare Advantage plans:
- Intravenous Immunoglobulin (IVIG)
- Subcutaneous Immunoglobulin (SCIG)
- Remicade® (infliximab)
- All Remicade’s biosimilar products
To help you submit preauthorization requests, Magellan Rx’s secure website at ih.MagellanRx.com (registration and log in required) is available 24 hours a day, seven days a week. The website will guide you through submitting the information needed for the review. Here are highlights of other features available through the Magellan Rx website.
